COVID - 19. Coronavirus infection, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients who at the same time with standard treatments, capsules containing olive leaf extract (capsules with a dose of 250 mg twice a day for five days) olive leaf
Sponsors
Khoram-Abad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: All patients with Quid-19 based on standard diagnostic test (positive PCR test, CT scan of lung) approved by infectious disease specialist Age range is 18 to 70 years Have a level of consciousness of 15 according to the Glasgow standard
Exclusion criteria
Exclusion criteria: Take oleopurine supplements 3 months before the study Use of mechanical ventilation equipment Existence of underlying respiratory diseases such as COPD, asthma Taking anti-hypertensive, anti-platelet and anti-diabetic drugs Pregnancy and lactation Immune system deficiency or the use of immunosuppressive drugs Malignancies Presence of heart, kidney, liver, blood pressure, diabetes and corticosteroid disorders Reluctance to continue cooperation The patient is discharged earlier than the completion of the treatment period Hypotension (mean arterial pressure less than 70 mm Hg) Hypoglycemia (blood sugar less than 75 mg / dL) Existence of allergies to drugs before and during the study Lack of proper use of drugs The need for therapeutic interventions other than the usual therapeutic interventions during research such as the need for dialysis, angioplasty and ... Participate in other research that in any way affects the results of the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Arterial oxygen saturation. Timepoint: Before starting the intervention, then for five days twice a day from 6 am to 6 pm. Method of measurement: Medair pulse oximeter device.;Heart rate. Timepoint: Before starting the intervention, then for five days twice a day from 6 am to 6 pm. Method of measurement: pulse oximeter device.;Temperatures. Timepoint: Before starting the intervention, then for five days twice a day from 6 am to 6 pm. Method of measurement: Digital thermometer.;Blood pressure. Timepoint: Before starting the intervention, then for five days twice a day from 6 am to 6 pm. Method of measurement: Hand pressure gauge.;Complete blood count. Timepoint: Before and during the intervention on a daily basis. Method of measurement: Patient file. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of general symptoms of Covid-19 disease. Timepoint: Before and during the intervention on a daily basis. Method of measurement: Symptom Severity Questionnaire.;Duration of hospitalization. Timepoint: Patient discharge time. Method of measurement: Counting the number of days the patient is hospitalized. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Ahmadpour
Khoram-Abad University of Medical Sciences
Outcome results
None listed